The way I see it, the results would be good and then there will either be a CR or a deal with a cornerstone investor. More likely to be the latter.
And since it is a 'short-term trial read-outs', my bet is on data readout from either the Vaxinia bile duct or OnCarlytic/Blincyto trial. Again, I suspect the latter and thereby the cornerstone investor could well be Amgen.
Above just my speculation.
Media Thread, page-15022
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.2¢ | 4.1¢ | $456.6K | 11.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 3248478 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 2261698 | 8 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |